Excess antivitamin K in elderly hospitalised patients aged over 70: A one-year prospective survey;Surdosages en antivitamine K dans une population de patients hospitalisés âgés de plus de 70 ans: Enquête prospective sur un an

Presse Medicale

Volumn 32, Issue 21, 2003, Pages 972-977

  Siguret, Virginie ^a,d   Esquirol, C ^a   Debray, M ^b,c   Gouin, I ^a   Andreux, J P ^a   Pautas, E ^b  

^a Laboratoire d'Hematologie   (France)

^b Unite de Geriatrie Aigue   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d HÔPITAL CHARLES FOIX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; AMIODARONE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIVITAMIN K; CEFTRIAXONE; COUMADINE; FLUCONAZOLE; FLUINDIONE; FUROSEMIDE; GALAXIE; METRONIDAZOLE; OFLOXACIN; PHYTOMENADIONE; ROXITHROMYCIN; WARFARIN;

AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; DRUG POTENTIATION; FEMALE; HOSPITALIZATION; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT MONITORING; PRESCRIPTION; PROSPECTIVE STUDY; RISK FACTOR;

4-HYDROXYCOUMARINS; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; ANTIFUNGAL AGENTS; COMA; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; FEMALE; HEMATOMA, SUBDURAL; HEMORRHAGE; HOSPITALIZATION; HUMANS; INDENES; INTERNATIONAL NORMALIZED RATIO; MALE; OVERDOSE; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; THROMBOCYTOPENIA; VITAMIN K; WARFARIN;

EID: 0037599535     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hirsh J, Dalen J, Anderson D et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119: 85-215.
2. Kniffin WD, Baron JA, Barrett J. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Int Med 1994; 154: 861-6.
3. Aronow WS, Ahn C, Gutstein H. Prevalence of atrial fibrillation and association of atrial fibrillation with prior and new thromboembolic stroke in older patients. J Am Geriatr Soc 1996; 44: 521-3.
4. Drouet L, Fiessinger JN, Boneu B, Decousus H. Mobilisation pour les antivitamines K. Sang Thrombose Vaisseaux 2000; 12: 347-9.
5. http://www.afssaps.sante.fr/
6. Fihn SD, McDonell M, Martin D et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med 1993; 118: 511-20.
7. Van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 1993; 153: 1557-62.
8. Levine MN, Chair MS, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119: 1085-215.
9. Ansell J, Hirsh J, Dalen J et al. Managing oral anticoagulant therapy. Chest 2001; 119: 225-385.
10. Taube J, Halsall D, Baglin T. Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment. Blood 2000; 96: 1816-19.
11. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interaction of warfarin with drugs and food. Ann Intern Med 1994; 121: 676-83.
12. Baglin T. Management of warfarin (coumarin) overdose. Blood Reviews 1998; 12: 91-8.
13. Adcock DM, Johnston M. Evaluation of frozen plasma calibrants for enhanced standardization of the International Normalized Ratio (INR): a multi-center study. Thromb Haemost 2002; 87: 74-9.
14. Murphy PT, Casey MC, Abrams K. Audit of patients on oral anticoagulants with international normalized ratios of eight or above. Clin Lab Haematol 1998; 20: 253-7.
15. Copland M, Walker I, Campbell Tait R. Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med 2001; 161: 2125-8.
16. Palareti G, Hirsh J, Legnani C et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. Arch Intern Med 2000; 160: 470-8.
17. Siguret V, Verny M, Sifer L, Stepanian A, Saint-Jean O, Andreux JP, Gaussem P. Predictive daily maintenance dose of warfarin in elderly patients. Thromb Haemost 1997, suppl (abstract): 705
18. Schved JF, de Moerloose P, Jude B, Toulon P. Utilisation des antivitamines K en pratique courante. Sang Thrombose Vaisseaux 2000; 12: 26-39.
19. Redwood M, Taylor C, Bain BJ, Matthews JH. The association of age with dosage requirement for warfarin. Age Ageing 1991; 20: 217-20.
20. Panneerselvam S, Baglin C, Lefort W, Baglin T. Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin. Brit J Haematol 1998; 103: 422-4.
21. Palareti G, Leali N, Coccheri S et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996; 348: 423-8.
22. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996; 124: 970-9.
23. Henderson MC, White RH. Anticoagulation in the elderly. Curr Opin Pulm Med 2001, 7: 365-70.
24. Sanoski CA, Bauman J.-L. Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy. Chest 2002, 121: 19-23.